Black Diamond Ventures

Black Diamond Ventures

Chris Lucas launched Black Diamond Ventures in 1998, drawing on a venture lineage that includes family-anchored early investments in Advanced Fibre Communications and Cadence Design Systems. Lucas received an MBA from USC and a BS in mechanical engineering from UCLA before spending two decades in venture-backed operating roles, experience he distilled into a Glendale-based firm with a secondary office in Los Gatos. Unlike a traditional blind-pool fund, BDV structures investments on a deal-by-deal basis, a model that allows accredited individuals, family offices, and institutional LPs to commit capital selectively rather than through a closed-end vehicle. BDV operates across the biotech, deep tech, and med tech sectors, targeting companies raising Series B through growth capital. Initial and follow-on checks range from $2 million to $10 million, with the firm taking board seats or observer roles in portfolio companies to provide operational support. The firm’s investment interests extend into verticals within deep tech, including AI, big data, machine learning, materials science, and semiconductors. Its disclosed portfolio illustrates this technical bent: Lyric Bio is utilizing ultra-fast bioprinting technology licensed from Prellis Biologics to manufacture donor-derived therapies in bioreactors; Strateos operates a fully automated robotic cloud laboratory for drug discovery; and Tela Innovations develops lithography optimization for semiconductor manufacturing. Historical liquidity events include DexCom, DivX Networks, and Forece10 Networks. A team of seven named professionals executes this strategy from Southern California and a Silicon Valley outpost in Los Gatos. Alongside Lucas and Managing Partner Ana Quintana — who joined the firm with over 20 years of VC and startup operating experience — four Venture Partners anchor BDV’s sourcing and advisory capabilities. John Kispert, the former CEO of Spansion, leads the Los Gatos office and fundraising efforts for the deal-by-deal structure. Jon Kraft, a co-founder of Pandora Media, advises founders through his Los Angeles accelerator, LiftOff. David Lynch, PhD, provides life-science domain expertise as the former CEO of Strateos, and Darryl Wash contributes over 40 years of institutional investing and investment-banking experience from Goldman Sachs and Peter J. Solomon Company. The firm’s website contact form specifies minimum LP check sizes of $2 million for the fund. BDV occupies an unusual lane in venture capital by combining a generalist firm’s sector appetite with a syndicate-style funding structure more common among angel networks. While it competes with multi-stage venture firms for biotech and deep tech allocation, its lack of a committed blind-pool fund and its reliance on episodic LP syndication differentiate it from most institutional managers. Christopher Lucas, now over three decades into his venture career, appears to have succession embedded: managing partner Ana Quintana drives the firm’s investment initiatives and portfolio-company support, suggesting a transition pathway that avoids single-key-person dependency at the top.